Is Dr Agarwals Eye Hospital Ltd (526783) a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Dr Agarwals Eye Hospital Ltd is a good quality company .

Is Dr Agarwals Eye Hospital Ltd (526783) undervalued or overvalued?

The key valuation ratios of Dr Agarwals Eye Hospital Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone .

What is Dr Agarwals Eye Hospital Ltd (526783) share price return in the past 10 years?

Dr Agarwals Eye Hospital Ltd share price has appreciated 39.3% annually (CAGR) over the past ten years.

Is Dr Agarwals Eye Hospital Ltd (526783) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Dr Agarwals Eye Hospital Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the share price of Dr Agarwals Eye Hospital Ltd (526783)?

Company share prices are keep on changing according to the market conditions. The current trading price of Dr Agarwals Eye Hospital Ltd (526783) on 17-Apr-2026 16:59:59 at 16:59 is 4768.80.

What is the P/E ratio of Dr Agarwals Eye Hospital?

The latest standalone P/E ratio of Dr Agarwals Eye Hospital as of 17-Apr-2026 is 32.99.

What is the P/B ratio of Dr Agarwals Eye Hospital Ltd (526783)?

The latest standalone P/B ratio of Dr Agarwals Eye Hospital Ltd (526783) as of 17-Apr-2026 is 6.94.

What is the 52-week high and low of Dr Agarwals Eye Hospital Ltd (526783)?

The 52-week high of Dr Agarwals Eye Hospital Ltd (526783) is Rs. 6392.00 and the 52-week low is Rs. 3866.90.

Dr Agarwals Eye Hospital Ltd (526783) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Dr Agarwals Eye Hospital Ltd (526783)
Brand: Dr Agarwals Eye Hospital

Dr Agarwals Eye Hospital Ltd (526783) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Dr Agarwals Eye Hospital Ltd (526783)

BSE: 526783 NSE:

Key Metrics

Market Cap

₹2,305 Cr.

P/E Ratio

32.99

Price to Book (P/B)

6.94

Price to Sales (P/S)

5.11

EV/EBITDA

16.17

Return on Capital Employed (ROCE)

33.26%

Current Price

₹4,768.8

Return on Equity (ROE)

29.80%

Return on Assets (ROA)

8.97%

Operating Profit Margin

30%

Net Profit Margin

13.76%

Gross Profit Margin

27.7%

Book Value per Share

₹686.7

Sales Growth (YoY)

24.38%

Sales Growth (3 Years)

25.44%

Operating Profit Growth (1 Year)

29.57%

Operating Profit Growth (3 Years)

26.66%

Net Profit Growth (1 Year)

17.88%

52-Week Low / High

₹3,867 / 6,392

Net Profit Growth (3 Years)

31.38%

Dividend Yield

0.15%

Promoter Holding

72.67%

Pledged shares (%)
of Promoter's holding (%)

29.26%

Check Before You Invest

Q.1 Revenue growth of Dr Agarwals Eye Hospital Ltd?

Dr Agarwals Eye Hospital Ltd revenue growth is 24.4% for FY-2025 , which is above its 5 year CAGR of 17.7% , indicating faster growth.

Q.1 Promoter shareholding and pledge status of Dr Agarwals Eye Hospital Ltd?

Promoters hold 72.67% of the Dr Agarwals Eye Hospital Ltd, with 29.26% of their stake pledged, indicating high pledge risk.

Q.1 Revenue growth of Dr Agarwals Eye Hospital Ltd vs industry peers?

Dr Agarwals Eye Hospital Ltd revenue CAGR is 17.68% , compared to the industry median CAGR of 1.49% , indicating faster growth and gaining its market share.

Q.1 Which industry/sub-sector does Dr Agarwals Eye Hospital Ltd belong to?

Dr Agarwals Eye Hospital Ltd belongs to the Healthcare sector, operating specifically within the Hospital & Healthcare Services segment.

Q.1 Stock return of Dr Agarwals Eye Hospital Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 38.9% based on the current price.

DeciZen - make an informed investing decision on Dr Agarwals Eye Hsp

Based on:

Data

Overall Rating ⓘ
Login to view analysis.

1. Quality

2. Valuation ⓘ

3. Price Trend

Dr Agarwals Eye Hospital stock performance

Key Ratios

Is Dr Agarwals Eye Hospital Ltd an attractive stock to invest in?

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	7.7%	28.3%	31.7%	34.3%	39.9%	16.9%	42.4%	43%	38.6%	33.3%	-
Value Creation Index ⓘ	-0.5	1.0	1.3	1.5	1.9	0.2	2.0	2.1	1.8	1.4	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	137	149	153	170	176	140	201	268	319	397	451
Sales YoY Gr.	-	8.8%	3.2%	10.9%	3.5%	-20.5%	43.9%	33.2%	19.1%	24.4%	-
Adj EPS ⓘ	-0.1	16.2	14.5	25.3	29.3	-3	51	78.7	99	115.3	144.5
YoY Gr.	-	NA	-10.5%	74.2%	15.7%	-110.3%	NA	54.4%	25.8%	16.5%	-
BVPS (₹) ⓘ	49.8	62.6	74.6	97	119.4	116.3	166.3	241.2	334.4	446	686.7
Adj Net Profit ⓘ	-0	7.6	6.8	11.9	13.8	-1.4	24	37	46.5	54.2	70
Cash Flow from Ops. ⓘ	17.4	20.1	18.6	25.1	38.6	33.9	56.7	69.6	89.8	94.5	-
Debt/CF from Ops. ⓘ	1.8	1.2	1	1	0.5	0.6	0.6	0.6	0.6	1	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	12.6%	17.7%	25.4%	24.4%
Adj EPS ⓘ	NA	31.5%	31.3%	16.5%
BVPSⓘ	27.6%	30.2%	38.9%	33.4%
Share Price	39.3%	71.1%	61%	16%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	-0.2	28.9	21.2	29.5	27.1	-2.6	36.1	38.6	34.4	29.6	25.5
Op. Profit Mgn % ⓘ	9	15.2	15.9	17.6	26.9	21.4	29.2	28.3	28.9	30.1	31.8
Net Profit Mgn % ⓘ	-0	5.1	4.5	7	7.8	-1	11.9	13.8	14.6	13.7	15.5
Debt to Equity ⓘ	1.3	0.8	0.5	0.5	0.3	0.4	0.4	0.4	0.3	0.5	-
Working Cap Days ⓘ	114	112	117	124	131	150	103	92	94	103	37
Cash Conv. Cycle ⓘ	-14	-19	-23	-22	-10	-15	-30	-32	-26	-18	-1

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	144.5	-
TTM Sales (₹ Cr.)	451	-
BVPS (₹) ⓘ	686.7	-
Reserves (₹ Cr.) ⓘ	327	-
P/BV ⓘ	6.94	-
PE ⓘ	32.99	-

From the Market
52 Week Low / High (₹)	3866.90 / 6392.00
All Time Low / High (₹)	2.10 / 7300.00
Market Cap (₹ Cr.)	2,305
Equity (₹ Cr.)	4.8
Face Value (₹)	10
Industry PE ⓘ	86.1

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

39.95

0.00

55.45

29.26

* Pledged shares as % of Promoter's holding (%)

Valuation of Dr Agarwals Eye Hsp - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	137	149	153	170	176	140	201	268	319	397
Operating Expenses ⓘ +	124	126	129	140	129	110	143	192	227	278
Manufacturing Costs	29	26	27	30	31	27	35	47	58	65
Material Costs	34	35	34	38	40	33	47	61	71	90
Employee Cost	29	32	32	34	36	32	39	53	64	78
Other Costs ⓘ	32	33	36	39	22	18	23	31	35	45
Operating Profit ⓘ	12	22	24	30	47	30	59	76	92	119
Operating Profit Margin (%)	9.0%	15.0%	15.8%	17.6%	26.8%	21.3%	29.1%	28.3%	28.8%	30.0%
Other Income ⓘ +	0	2	2	2	3	2	1	2	5	6
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	5	4	3	4	9	7	7	8	8	15
Depreciation ⓘ	9	9	10	11	21	19	20	20	27	39
Profit Before Tax ⓘ	-0	11	13	17	20	6	32	49	62	71
Tax ⓘ	-1	4	7	6	6	7	8	12	16	16
Profit After Tax	0	7	7	12	14	-1	24	37	46	55
PAT Margin (%)	0.0%	4.9%	4.4%	7.0%	7.8%	-1.0%	12.0%	13.8%	14.5%	13.8%
Adjusted EPS (₹)	0.1	15.6	14.4	25.4	29.1	-3.1	51.3	78.6	98.6	116.3
Dividend Payout Ratio (%)	1,024%	10%	8%	6%	0%	0%	6%	4%	5%	5%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	23	29	35	46	56	55	78	113	157	210
Share Capital ⓘ	5	5	5	5	5	5	5	5	5	5
Reserves ⓘ	19	25	30	41	51	50	73	109	152	205
Debt +	24	16	10	18	13	17	27	40	44	82
Long Term Debt	18	13	5	13	8	10	21	36	44	82
Short Term Debt	6	3	5	5	5	7	6	4	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	18	14	18	15	14	18	26	27	32	30
Others Liabilities ⓘ	19	22	33	41	83	78	203	242	308	355
Total Liabilities ⓘ	84	81	96	120	166	167	333	422	541	677
Fixed Assets
Net Fixed Assets ⓘ +	34	33	36	55	94	96	214	260	316	393
Gross Block	87	37	49	78	138	158	295	365	446	562
Accumulated Depreciation	53	4	13	23	44	62	81	104	131	169
CWIP ⓘ	1	1	3	0	0	0	26	62	97	128
Investments ⓘ	0	0	0	0	0	0	0	0	0	13
Inventories	10	6	7	6	8	5	6	6	10	13
Trade Receivables	9	7	7	9	7	9	9	10	13	14
Cash Equivalents	2	3	2	5	7	22	29	28	34	12
Others Assets ⓘ	28	31	40	45	51	36	49	55	72	104
Total Assets ⓘ	84	81	96	120	166	167	333	422	541	677

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	17	20	19	25	39	34	57	70	90	94
PBT ⓘ	-0	11	13	17	20	6	32	49	62	71
Adjustment ⓘ	15	11	13	13	28	27	27	27	31	50
Changes in Working Capital ⓘ	5	1	-2	3	-3	4	6	5	10	-6
Tax Paid ⓘ	-3	-3	-5	-8	-7	-3	-9	-12	-14	-20
Cash Flow From Investing Activity ⓘ +	-17	-8	-11	-25	-17	-11	-46	-71	-70	-133
Capex	-17	-8	-11	-25	-17	-11	-46	-70	-70	-102
Net Investments	-0	-0	0	-0	0	-0	-0	-0	-1	-30
Others ⓘ	0	1	1	0	0	0	0	-0	1	0
Cash Flow From Financing Activity ⓘ +	-0	-12	-8	2	-20	-8	-4	0	-14	17
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	6	-5	-7	6	-6	2	11	20	9	37
Interest Paid ⓘ	-4	-3	-3	-3	-3	-2	-2	-2	-0	-3
Dividend Paid ⓘ	-1	-0	-1	-1	-1	-0	-0	-1	-3	-2
Others ⓘ	-2	-3	2	0	-10	-7	-13	-17	-20	-15
Net Cash Flow ⓘ	0	0	-0	2	2	15	7	-1	6	-22

Finance Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	0.16	27.78	21.02	29.55	26.91	-2.6	36.29	38.56	34.28	29.8
ROCE (%)	7.7	28.26	31.7	34.3	39.87	16.92	42.4	42.98	38.59	33.26
Asset Turnover Ratio	1.8	1.8	1.73	1.57	1.23	0.84	0.8	0.71	0.66	0.65
PAT to CFO Conversion(x)	N/A	2.86	2.71	2.08	2.79	N/A	2.38	1.89	1.96	1.71
Working Capital Days
Receivable Days	20	19	16	17	16	20	16	13	13	12
Inventory Days	27	20	16	15	15	17	10	8	9	11
Payable Days	184	167	171	159	131	176	170	157	151	126

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Dr Agarwals Eye Hospital Ltd FAQs

The current trading price of Dr Agarwals Eye Hsp on 17-Apr-2026 16:59 is ₹4,768.8.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 16-Apr-2026 the market cap of Dr Agarwals Eye Hsp stood at ₹2,304.7 Cr

The latest P/E ratio of Dr Agarwals Eye Hsp as of 16-Apr-2026 is 32.99.

The latest P/B ratio of Dr Agarwals Eye Hsp as of 16-Apr-2026 is 6.94.

The 52-week high of Dr Agarwals Eye Hsp is ₹6,392 and the 52-week low is ₹3,866.9.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Dr Agarwals Eye Hsp is ₹451 ( Cr.) .

About Dr Agarwals Eye Hospital Ltd

Dr Agarwal’s Eye Hospital, founded in 1957 and registered in 1994 as a Company, is a leading chain of eye hospitals with predominant presence in Tamil Nadu. Under the able leadership of Dr Amar Agarwal, the company has been a pioneer and leader in the Ophthalmology market with an established market position and healthy brand recall in the eye care segment. It offers comprehensive services in the eye-care segment including Cataract, Glaucoma, Laser Correction, Cornea and Refractive, Retina, and Squint among others. The company provides comprehensive services across all major ophthalmic specialities. It offers comprehensive services in the eye-care segment including Cataract, Glaucoma, Laser Correction, Cornea and Refractive, Retina, and Squint among others. The hospital uses advanced diagnostic technology, precision surgical systems and global best practices to ensure accurate treatment outcomes. Each speciality is supported by dedicated teams trained in complex procedures and emerging innovations.

Business area of the company

Dr Agarwals Eye Hospital is primarily engaged in running, owning and managing eye care hospitals, opticals, pharmacies, etc. and related services.

Eye Treatments & Surgery

Trabeculectomy Surgery for Glaucoma
Glaucoma Shunt Surgery
Silk LASIK
Laser Trabeculoplasty for Glaucoma Treatment
YAG Peripheral Iridotomy (YAG PI)
Minimally Invasive Glaucoma Surgery (MIGS)
Robotic Cataract
Central Serous Retinopathy (CSR)
Hyperopia
Stye Eye Treatment
Refractive Surgery
Myopia
Contoura Lasik
Lasik Surgery
Flapless LASIK
Photorefractive Keratectomy (PRK)
Implantable Collamer Lens (ICL)
Eyelid & Eye Socket Correction (Oculoplasty)
Glued IOL
CAIRS Eye Surgery
Advanced Corneal Transplant (PDEK)
Pneumatic Retinopexy (PR)
Cornea Transplantation
Pinhole Pupilloplasty
Paediatric Ophthalmology
Cryopexy
Retina Injection Therapy (Anti-VEGF)
Cosmetic Eye Surgery
Dry Eye Treatment
Retinal Laser Photocoagulation
Retina Repair Surgery (Vitrectomy)
Scleral Buckle
Laser Cataract Surgery
Black Fungus Treatment & Diagnosis
Neuro Ophthalmology

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Dr Agarwals Eye Hospital Ltd (526783) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Dr Agarwals Eye Hsp Share Price